孤儿受体GPR88调控冲动性并是注意缺陷多动障碍的风险因素
该研究结合Gpr88敲除小鼠行为学与567个ADHD核心家系遗传学,发现GPR88缺陷可因果性促进ADHD样行为,且GPR88变异与ADHD诊断、治疗反应及认知存在关联,提示GPR88信号是ADHD诊疗的关键因素。
要点
- Gpr88敲除小鼠表现出高运动冲动性、注意力下降及多动。
- 托莫西汀可降低突变小鼠的冲动性。
- SNP rs2809817的T等位基因在产前应激下为ADHD风险因素。
核心结论
- 动物与人类数据一致提示GPR88信号应被视为ADHD诊断和治疗的关键因素。
研究设计与样本
- 小鼠行为学实验测试Gpr88敲除小鼠在三种行为范式中的表现。
- 人类遗传学采用567个核心家系的家族关联研究,ADHD诊断依据DSM-IV。
主要发现
- Gpr88敲除小鼠表现出更高的运动冲动性和注意力下降,并伴有已报道的多动。
- D1R型或D2R型中型棘神经元条件性敲除Gpr88揭示两类受体群体在等待和停止冲动性中的不同作用。
- SNP rs2036212与ADHD诊断、治疗反应和认知存在次要关联。
- SNP rs2809817在患者分层后显示更强关联,提示产前应激下T等位基因为风险因素。
关键数值与推荐
- 托莫西汀降低了突变小鼠的冲动性。
- SNP rs2036212与诊断、治疗反应和认知的关联为次要关联。
- SNP rs2809817的T等位基因在涉及产前应激时为风险因素。
临床怎么用
- GPR88信号可作为ADHD诊断与治疗的潜在关键因素进行考量。
- 生命轨迹(如产前应激)可能调节GPR88功能,影响风险解读。
局限性
- 人类遗传学中rs2036212的关联仅为次要关联。
- rs2809817的更强关联依赖于患者分层,提示结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The neural orphan G protein coupled receptor GPR88 is predominant in the striatum and cortex of both rodents and humans, and considered a potential target for brain disorders. Previous studies have shown multiple behavioral phenotypes in Gpr88 knockout mice, and human genetic studies have reported association with psychosis. Here we tested the possibility that GPR88 contributes to Attention Deficit Hyperactivity Disorder (ADHD). In the mouse, we tested Gpr88 knockout mice in three behavioral paradigms, best translatable between rodents and humans, and found higher motor impulsivity and reduced attention together with the reported hyperactivity. Atomoxetine, a typical ADHD drug, reduced impulsivity in mutant mice. Conditional Gpr88 knockout mice in either D1R-type or D2R-type medium spiny neurons revealed distinct implications of the two receptor populations in waiting and stopping impulsivity. Thus, animal data demonstrate that deficient GPR88 activity causally promotes ADHD-like behaviors, and identify circuit mechanisms underlying GPR88-regulated impulsivity. In humans, we performed a family-based genetic study including 567 nuclear families with DSM-IV diagnosis of ADHD. There was a minor association for SNP rs2036212 with diagnosis, treatment response and cognition. A stronger association was found for SNP rs2809817 upon patient stratification, suggesting that the T allele is a risk factor when prenatal stress is involved. Human data therefore identify GPR88 variants associated with the disease, and highlight a potential role of life trajectories to modulate GPR88 function. Overall, animal and human data concur to suggest that GPR88 signaling should be considered a key factor for diagnostic and treatment of ADHD.
引用
- Ben Hamida S, Sengupta SM, Clarke E, et al. The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder. Mol Psychiatry. 2022. PMID: 36075963. doi:10.1038/s41380-022-01738-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。